Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -174,298 | -82,852 | -201,592 | -122,022 | -78,779 |
| Depreciation Amortization | 1,385 | 688 | 2,452 | 1,701 | 1,038 |
| Accounts receivable | -9,240 | -2,243 | -1,637 | N/A | N/A |
| Other Working Capital | -7,647 | -7,021 | -13,644 | -14,320 | -11,908 |
| Other Operating Activity | 50,059 | 22,408 | 76,841 | 40,858 | 27,780 |
| Operating Cash Flow | $-139,741 | $-69,020 | $-137,580 | $-93,783 | $-61,869 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -86 | -40 | -1,634 | -1,159 | -220 |
| Investing Cash Flow | $-86 | $-40 | $-1,634 | $-1,159 | $-220 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 34,650 | 9,900 | 39,318 | N/A | N/A |
| Common Stock Issued | 21 | N/A | 155,587 | 155,587 | 155,574 |
| Other Financing Activity | 0 | 0 | 172,675 | 0 | 0 |
| Financing Cash Flow | $34,671 | $9,900 | $367,580 | $155,587 | $155,574 |
| Beginning Cash Position | 384,256 | 384,256 | 155,890 | 155,890 | 155,890 |
| End Cash Position | 279,100 | 325,096 | 384,256 | 216,535 | 249,375 |
| Net Cash Flow | $-105,156 | $-59,160 | $228,366 | $60,645 | $93,485 |
| Free Cash Flow | |||||
| Operating Cash Flow | -139,741 | -69,020 | -137,580 | -93,783 | -61,869 |
| Capital Expenditure | -86 | -40 | -1,634 | -1,159 | -220 |
| Free Cash Flow | -139,827 | -69,060 | -139,214 | -94,942 | -62,089 |